News
-
-
PRESS RELEASE
Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market
Zomedica Corp. to review Q1 2026 financial results and discuss the companion animal market during 'Fifth Friday at Four' investor webinar on May 29, 2026 at 4:00 p.m. Eastern Time -
-
PRESS RELEASE
Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Zomedica reports record first quarter revenue surpassing $8 million for the 21st straight quarter, driven by strong product performance and international sales. Financial metrics show growth and expense management -
-
PRESS RELEASE
Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Zomedica announces webinar showcasing manufacturing operations for investors, providing insight into quality systems and scalable product fulfillment -
-
PRESS RELEASE
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp. announces collaboration with Boehringer Ingelheim Animal Health USA Inc. to enhance early detection along with treatment and monitoring of pituitary pars intermedia dysfunction (PPID) in horses -
-
PRESS RELEASE
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Zomedica reports record $10 million quarterly revenue, 20th consecutive year-over-year growth. Financial highlights and strategic outlook unveiled
